Abstract
Objective
To evaluate the effect and safety of Pingchuan Yiqi Granule (平喘益气颗粒, PYG) in treating bronchial asthma of qi-deficiency cold syndrome type (BS-QDC).
Methods
With the randomized, positive agent parallel controlled design adopted, the 80 subjects enrolled were assigned in the ratio of 3:1 to two groups, the 60 patients in the trial group were treated with PYG and the 20 in the control group treated with Ruyi Dingchuan Pill (如意定喘丸, RDP), with the therapeutic course consisting of 7 days for both groups. The clinical effects, effects on TCM syndrome and the changes of lung function after treatment were observed.
Results
The effect of the treatment on asthma in the trial group: clinically controlled rate was 6.67%, markedly effective rate 51.67%, improved rate 33.33% and ineffective rate 8.33%; and the corresponding rates in the control group were 5.00%, 50.00%, 30.00%, and 15.00% respectively. Comparison between the two groups showed insignificant difference (P>0.05). The effect on TCM syndrome in the treated group: clinically controlled rate was 11.67%, markedly effective rate 58.33%, effective rate 21.67% and ineffective rate 8.33%; and those in the control group were 10.00%, 50.00%, 30.00% and 10.00% respectively, also showing insignificant difference between the two groups (P>0.05). Lung function test showed that the change on forced expiratory volume in 1 second (FEV1) after treatment in the trial group was of statistical significance (P<0.05), but no significant difference was shown in the change of peak expiratory flow (PEF, P>0.05); while the changes in the control group were just the opposite, showing insignificance in FEV1 (P>0.05) but significance in PEF (P<0.05). Comparison of the therapeutic effect on lung function between the two groups showed no significant difference (P>0.05). No adverse reaction was found in either group in the course of treatment.
Conclusion
PYG used to treat BS-QDC is effective and safe, it’s effect is similar to that of RDP.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ministry of Health, P.R.C. Principle of guidance on clinical study of TCM new drugs. Vol. 1. 1993: 6–10.
Branch of Respiratory Diseases of the Chinese Association of Medicine. Directory of bronchial asthma prevention and treatment. Chin J Tuberc Respir Dis 1997; 20(5): 261–267.
State Supervisory Administration of Foods and Drugs. Technologic requirement for researches of TCM new drugs. 1999: 34–37.
Ya Ka zu Doumei. Explanation on the recipes used in clinic. Beijing: People’s Medical Publishing House, 1983: 221.
Li BG. Treatment of children asthma with Shenmi Decoction. J Pract Tradit Chin Med 2000;14(1): 45.
Fang D, Kou TQ. Twenty-nine patients of chronic asthmatic bronchitis in acute stage treated mainly with Shenmi Decoction. J Pract Tradit Chin Med 1998;14(3): 11.
Zand LJ. Treatment of chronic cough and asthma with Kampo medicine. Foreign Med Sci (Tradit Chin Med) 2005;27(5): 290–293.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhang, Y., Chang, J., Chi, Hh. et al. Randomized controlled trial on treatment of bronchial asthma of qi-deficiency cold syndrome type by Pingchuan Yiqi Granule (平喘益气颗粒). Chin. J Integ. Med. 13, 27–32 (2007). https://doi.org/10.1007/s11655-007-0027-7
Received:
Issue Date:
DOI: https://doi.org/10.1007/s11655-007-0027-7